Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2004 020 337.8 |
| 96 | EP file number | EAKZ | 04 01 9003.5 |
| 97 | EP publication number | EPN | 1632229 |
| 54 | Designation/title | TI | Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/4439 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/46 (2006.01), A61K 31/14 (2006.01), A61P 13/02 (2006.01) |
| 22 | DE application date | DAT | Aug 11, 2004 |
| 96 | EP application date | EAT | Aug 11, 2004 |
| 43 | Date of first publication | OT | Mar 8, 2006 |
| Date of publication of grant | PET | Apr 1, 2009 |
| 71/73 | Applicant/owner | INH | Boehringer Ingelheim Pharma GmbH & Co. KG, 55218 Ingelheim, DE |
| 72 | Inventor | IN | Pieper, Michael P., 88400 Biberach, DE |
| Address for service | | Boehringer Ingelheim GmbH, 55216 Ingelheim, DE |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001632229
Searchable text:
EP000001632229
Original document:
EP000001632229B1
Searchable text:
EP000001632229B1 |
| 43 | Date of first publication | EVT | Mar 8, 2006 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2022
(Show all update days)(Hide all update days)- Jan 5, 2022; May 25, 2016; Apr 16, 2016; Apr 28, 2015; Aug 30, 2014; Sep 10, 2013; Aug 31, 2013; Jan 28, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
